Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism FGFRs antagonists(Fibroblast growth factor receptors antagonists), VEGFR antagonists(Vascular endothelial growth factor receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cancer | Phase 1 | CN | 29 Aug 2022 | |
Advanced Malignant Solid Neoplasm | Phase 1 | CN | 20 Jul 2021 |